Altos labs

altos labs

What is Altos labs?

The name Altos Labs is based on the city of Los Altos in California. The idea for Altos Labs originated with cell biologist and entrepreneur Richard D. Klausner, who co-founded the company with Hans Bishop.

Is Altos Labs working on an extension of human lifespan?

In January 2022 the companys president, Hans Bishop, argued, that Altos Labs was working on increasing the healthspan of humans and that longevity extension would only be an accidental consequence. ^ a b c A $3bn bet on finding the fountain of youth.

Who is Altos Labs CEO Michael Klausner?

Klausner, who previously helped start companies like Juno Therapeutics and cancer-test company Grail, is known for organizing large, and lucrative, financial bets on new biotechnologies. According to an incorporation filing in the UK for Altos Labs, Klausner is CEO of the new company.

Do Mega-startups like Alta labs have a Pharma-like problem?

A potential pharma-like problem with mega-startups like Alta Labs is that they put too much money in too few hands and in doing so, reduce innovative diversity. Can Alta make more and better drugs than could, say, fifty $60-million start-ups?

Where is Altos labs located?

Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine. Where is Altos Labs s headquarters? Altos Labs is located in San Francisco, California, United States.

What is the philosophy of Altos labs?

“The philosophy of Altos Labs is to do curiosity-driven research. This is what I know how to do and love to do,” says Serrano, who plans to move to Cambridge, UK to join an Altos facility there. “In this case, through a private company, we have the freedom to be bold and explore.

What is Altos?

The Altos Board of Directors and advisors include Nobel Laureates and scientific leaders. Altos is dedicated to unraveling the deep biology of cellular rejuvenation programming. Our mission is to restore cell health and resilience to reverse disease, injury, and disabilities that occur throughout life.

Will Altos labs be a different beast?

Perhaps Altos Labs will be a different beast, given the apparent focus on cellular reprogramming. We can certainly hope so. Last October, a large group of scientists made their way to Yuri Milners super-mansion in the Los Altos Hills above Palo Alto.

Who is the CEO of Altos labs?

According to an incorporation filing in the UK for Altos Labs, Klausner is CEO of the new company. Klausner did not respond to attempts to contact him by email and phone. Like Milner, he also lives in Los Altos Hills.

Who is on the Altos executive team?

The Altos executive team will be composed of Hal Barron, MD (incoming CEO), Rick Klausner, MD (Chief Scientist and Founder), Hans Bishop (President and Founder), and Ann Lee-Karlon, PhD (Chief Operating Officer).

Is Altos Labs working on an extension of human lifespan?

In January 2022 the companys president, Hans Bishop, argued, that Altos Labs was working on increasing the healthspan of humans and that longevity extension would only be an accidental consequence. ^ a b c A $3bn bet on finding the fountain of youth.

What is the philosophy of Altos labs?

“The philosophy of Altos Labs is to do curiosity-driven research. This is what I know how to do and love to do,” says Serrano, who plans to move to Cambridge, UK to join an Altos facility there. “In this case, through a private company, we have the freedom to be bold and explore.

A potential pharma-like problem with mega-startups like Alta Labs is that they put too much money in too few hands and in doing so, reduce innovative diversity. Can Alta make more and better drugs than could, say, fifty $60-million start-ups?

What does Alta laboratories’ $3 billion investment mean for biopharma?

The launch of Alta Laboratories with a $3 billion initial commitment-likely the world record startup financing by an order of magnitude or more-says a lot about the state of venture capital, biopharma, financial markets, innovation and human nature. Money made the bio-venture business model possible. Will more push it to new heights or off a cliff?

Are there any startups working on solutions for the pharmaceutical sector?

Postagens relacionadas: